ALNEV — Neovacs SA Share News
0.000.00%
Last trade - 00:00- €0.01m
- -€0.03m
- €0.16m
Brief: Neovacs Announces Fundraising Of EUR 1 Million
Brief: Neovacs: Fund Raising Of EUR 3 Million
Brief: Neovacs H1 Net Loss Widens To 6.4 Million Euros
Brief: Neovacs: Capital Raising Of 1 Million Euros
Brief: Neovacs Raises EUR 2 Million To Finance Strategic Plan
Brief: Neovacs Files New Patent In Food Allergies
Brief: Neovacs Launches Second COVID-19 Start-Up Fund Recruitment Campaign
Brief: Neovacs Announces Creation Of A COVID-19 Start-Up Fund
Brief: Neovacs: Drawing ORNANE Tranche With Nominal Value Of €500,000
Brief: Neovacs Draws Convertible Bonds (ORNANE) Tranche Of EUR 0.5 Million
Brief: Neovacs Announces Start Of Strategic Plan To Relaunch Research
Brief: Neovacs FY Net Loss Narrows To 7.5 Million Euros
Brief: Neovacs' EGM Allows Funding Programme, Implementation Of Strategic Plan
Brief: Neovacs Says Court Reserves Decision On Famar Lyon Takeover
Brief: Neovacs Announces Famar Lyon Acquisition Project
Brief: Neovacs: Conversion Of 107 Convertible Bonds (ORNANE) By HBR Investment Group
Brief: Neovacs Shares To Resume Trading On May 20th
Brief: Neovacs: Validation Of "Restarted" Plan By Paris Commercial Court
Brief: Neovacs Announces Commercial Court Of Paris' Decision To Open Insolvency Procedure